---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-042513"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:18:54.203295+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell Therapeutics removes Leerink Partners as ATM selling agent

## Summary
- Amendment No. 1 to Distribution Agreement dated April 2, 2024 removes Leerink Partners as agent.
- Raymond James remains as the sole agent under the existing $100M ATM equity program.
- Original Distribution Agreement was entered August 9, 2021; no change to offering size or terms.
- Company's common stock trades on Nasdaq under ticker BCLI.

## SEC filing metadata
- accession: 0001104659-24-042513
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/0001104659-24-042513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/tm2410454d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-042513
- JSON: https://secwatch.observer/filing/0001104659-24-042513.json
- Plain text: https://secwatch.observer/filing/0001104659-24-042513.txt

## Key facts
- Material Agreements
  BRAINSTORM CELL THERAPEUTICS INC. amended Distribution Agreement with Leerink Partners LLC (effective 2024-04-02).
  - Action: amendment
  - Agreement: atm program
  - Counterparty: Leerink Partners LLC
  - Effective: 2024-04-02
  source text: On April 2, 2024, the Company entered into an amendment No. 1 to the Distribution Agreement (“Amendment No. 1”) pursuant to which Leerink Partners ceased to be an agent under the Distribution Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/0001104659-24-042513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.